Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors

Overview of attention for article published in Frontiers in oncology, July 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 16 X posts from 8 X users, with an upper bound of 34,020 followers.

RT @DrSarcoma: In a preclinical model of the human disease…. But worth exploring lots of avenues in MPNST, for sure!

RT @DrSarcoma: In a preclinical model of the human disease…. But worth exploring lots of avenues in MPNST, for sure!

In a preclinical model of the human disease…. But worth exploring lots of avenues in MPNST, for sure!

RT @CrozrX: Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I #NF1 related malignant…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.